Thomas Sciascia
2022
In 2022, Thomas Sciascia earned a total compensation of $577.3K as Chief Scientific Officer at Trevi Therapeutics.
Compensation breakdown
| Bonus | $130,772 |
|---|---|
| Option Awards | $46,820 |
| Salary | $391,458 |
| Other | $8,245 |
| Total | $577,295 |
Sciascia received $391.5K in salary, accounting for 68% of the total pay in 2022.
Sciascia also received $130.8K in bonus, $46.8K in option awards and $8.2K in other compensation.
Rankings
In 2022, Thomas Sciascia's compensation ranked 4,110th out of 5,717 executives tracked by ExecPay. In other words, Sciascia earned more than 28.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,110 out of 5,717 | 28th |
Division Manufacturing | 2,320 out of 3,111 | 25th |
Major group Chemicals And Allied Products | 1,123 out of 1,410 | 20th |
Industry group Drugs | 1,053 out of 1,311 | 20th |
Industry Pharmaceutical Preparations | 770 out of 957 | 20th |
Source: SEC filing on April 26, 2024.
Sciascia's colleagues
We found two more compensation records of executives who worked with Thomas Sciascia at Trevi Therapeutics in 2022.